Reagents Sales Propel GenMark's Q3 Revenues up 162 Percent
November 04, 2010
Reagents Sales Propel GenMark's Q3 Revenues up 162 Percent
In addition to a 164 percent increase in reagent revenues to $581,000, GenMark also posted $72,000 in instruments and other product revenues, compared to none in the year-ago period.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.